1st Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

S.480/H.R.1725, "National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015," educating on the importance of PDMPs and the need for federal funding.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1725 (114th), S. 480 (114th)

Pharmacy PHA

S.524, Comprehensive Addiction and Recovery Act, focused on Prescription Drug Management Plans (PDMPs). H.R.4784, Lower Drug Costs Through Competition Act, support increasing generic availability. S.2680, A bill to amend the Public Health Service Act to provide comprehensive mental health reform, and for other purposes.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 524 (114th), H.R. 4784 (114th), S. 2680 (114th)

Medicare/Medicaid MMM

S.524 "Comprehensive Addiction and Recovery Act," focused on Prescription Drug Management Plans (PDMPs). H.R.244, "MAC Transparency Act," educating on how MAC pricing helps control costs for consumers. H.R.793/S.1190, "Ensuring Seniors Access to Local Pharmacies Act of 2015," importance of pharmacy networks in reducing costs. H.R.1600, "The Patients' Access to Treatment Act," educating on the importance of step therapy to ensuring optimal therapy access and cost control. S.480/H.R.1725, "National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015," educating on the importance of PDMPs and the need for federal funding.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 244 (114th), S. 524 (114th), H.R. 1600 (114th), S. 480 (114th), H.R. 793 (114th), H.R. 1725 (114th), S. 1190 (114th)

Health Issues HCR

S.524, "Comprehensive Addiction and Recovery Act," focused on Prescription Drug Management Plans (PDMPs). S.1945, Senate HELP mental health reform package, "Mental Health Reform Act of 2016," mental health parity treatment of step therapy and prior-authorization. S.2615, "Increasing Competition in Pharmaceuticals Act," support increasing generic availability. H.R.6, "The 21st Century Cures Act" and Senate companions, ensuring no new barriers to generic and biosimilar market entry. Generic Drug User Fee Act Reauthorization, support increasing generic availability. H.R.1600, "The Patients' Access to Treatment Act," educating on the importance of step therapy to ensuring optimal therapy access and cost control. S.480/H.R.1725, "National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015," educating on the importance of PDMPs and the need for federal funding.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1725 (114th), S. 480 (114th), H.R. 1600 (114th), S. 1945 (114th), S. 2615 (114th), S. 524 (114th), H.R. 6 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.